University of New Mexico Cancer Center Support

地处一个具有丰富的多元文化和多民族多样性的地区，具有巨大的科技能力， 新墨西哥大学癌症研究和治疗中心挑战健康和社会经济差异 (UNM CRTC)独一无二地准备为国家降低癌症发病率的使命做出重大贡献 并消除死亡和癌症的痛苦。UNM CRTC的特点是多民族 它所服务的人群具有截然不同的癌症发病率和死亡率模式， 将区域科技优势融入其研究计划以及广泛的网络和伙伴关系 它是为参与性的社区研究而开发的。由NCI P20癌症中心规划拨款资助 自2000年9月1日以来，该中心取得了巨大的进步。在重要的机构、国家和社区的支持下， CRTC聘请了36名新的癌症专家和科学家；将其年度NCI翻了一番(直接成本+9,730,273美元 UNM NCI SEER计划的直接费用为2,004,977美元)和同行评审的癌症资助总额(#年为25,257,828美元 直接成本和总成本为35,517,100美元)；与Lovelace呼吸研究中心的正式财团安排 研究所(LRRI)和与桑迪亚国家实验室的合作伙伴关系；新诊断患者数量翻了一番 在CRTC接受治疗；显著增加了患者对临床试验的参与度(35%的患者积累到 干预研究，13%用于治疗性研究)；并对服务不足和少数群体保持非常高的照顾率 患者(在一个33%的癌症病例发生在少数族裔的州，52%的患者在新墨西哥州接受治疗 CRTC是少数人；少数人对所有类型的癌症方案的应计收益为52%，对治疗研究的应计收益为38%)。这个 UNM CRTC的91个成员被分成4个研究计划：癌症流行病学和预防， 关注以下总体目标的癌症生物学、血液恶性肿瘤和女性癌症： 1.在我们的实验室、诊所和医院开展卓越的多学科和跨学科的癌症研究 建立在独特的机构和区域科学优势和协作研究基础上的社区 与洛夫莱斯呼吸研究所和新墨西哥州国家实验室的合作。 2.通过发现遗传、环境、社会和行为因素来降低癌症的发病率和死亡率 这导致了新墨西哥州多种族人口中截然不同的癌症模式。 3.通过以下方式减少西南地区历史上未得到充分服务的人口中的癌症健康差距 与州卫生部、新墨西哥州普韦布洛斯、部落和美国人合作的社区网络 印第安人国家、印度卫生服务机构和当地社区通过发展文化上合适的癌症 教育、筛查和预防方案。 4.为所有新墨西哥人提供出色的癌症治疗，改善获得高质量癌症护理和 通过更多的转介和与社区癌症护理提供者的正式联系来创新疗法。 5.增加新墨西哥人获得和参与癌症临床研究和癌症治疗的机会 和预防临床试验，由UNM-社区合作临床试验网络(The New 墨西哥癌症护理联盟)。

Located in a region of rich multicultural and multiethnic diversity, tremendous scientific and technological capability, and challenging health and socioeconomic disparity, The University of New Mexico Cancer Research and Treatment Center (UNM CRTC) is uniquely poised to make significant contributions to the Nation's mission to reduce cancer incidence and eliminate death and suffering from cancer. The special characteristics of the UNM CRTC are the multiethnic populations that it serves with their strikingly different patterns of cancer incidence and mortality, the integration of regional scientific and technologic strengths into its Research Programs, and the extensive networks and partnerships that it has developed for participatory community-based research. Funded by a NCI P20 Cancer Center Planning Grant since 9/1/2000, the Center has made tremendous progress. With significant institutional, State, and community support, the CRTC has hired 36 new cancer specialists and scientists; doubled its annual NCI ($9,730,273 in direct costs + $2,004,977 in direct costs to the UNM NCI SEER program) and total peer-reviewed cancer funding ($25,257,828 in direct and $35,517,100 in total costs); formalized consortium arrangements with the Lovelace Respiratory Research Institute (LRRI) and partnerships with Sandia National Laboratory; doubled the number of newly diagnosed patients treated at the CRTC; significantly increased patient participation in clinical trials (35% of all patients were accrued to intervention studies, 13% to therapeutic studies); and maintained very high rates of care to underserved and minority patients (in a State where 33% of cancer cases occur in ethnic minorities, 52% of the patients treated at the UNM CRTC were minorities; minority accrual to all types of cancer protocols was 52% and 38% to therapeutic studies). The 91 Members of the UNM CRTC are clustered into 4 Research Programs: Cancer Epidemiology and Prevention, Cancer Biology, Hematologic Malignancies, and Women's Cancers that are focused on the following overall goals: 1. To conduct outstanding multidisciplinary and trandisciplinary cancer research in our laboratories, clinics, and communities that builds on unique institutional and regional scientific strengths and collaborative research partnerships with the Lovelace Respiratory Research Institute and New Mexico's National Laboratories. 2. To reduce cancer incidence and mortality by discovering the genetic, environmental, social, and behavioral factors that contribute to the distinct cancer patterns in the multiethnic populations of New Mexico. 3. To reduce cancer health disparities in the historically underserved populations of the Southwest through collaborative community networks with the State Department of Health; New Mexico Pueblos, Tribes, and American Indian Nations; the Indian Health Service; and local communities by developing culturally appropriate cancer education, screening, and prevention programs. 4. To provide outstanding cancer treatment for all New Mexicans, by improving access to quality cancer care and innovative therapies through increased referrals and formal affiliations with community cancer care providers. 5. To increase access to and participation of New Mexicans in cancer clinical investigations and cancer therapeutic and prevention clinical trials, facilitated by a joint UNM-community collaborative clinical trials network (The New Mexico Cancer Care Alliance).